Literature DB >> 25034529

MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN.

Yao-Qi Yang1, Jin Qi, Jian-Qiang Xu, Ping Hao.   

Abstract

Menin, encoded by MEN1 gene, has been viewed as a tumor suppressor in several types of tumors, such as insulinoma, parathyroid tumor, and adrenocortical and lung carcinoma. However, its expression and molecular regulation mechanism in osteosarcoma has not been elucidated. Here, our results show menin expression is significantly down-regulated in osteosarcoma tissues, compared with adjacent normal tissues. Besides, we report that MicroRNA-142-3p as a novel target of menin. Up-regulation of MicroRNA-142-3p by menin overexpression inhibits cell proliferation in U2OS and MG63 cells. At the molecular level, MicroRNA-142-3p inhibits the protein expression of FASN through binding to its 3'-untranslated region. Therefore, we elucidate a novel regulation pathway in osteosarcoma cells and suggest a potential therapeutic approach for the tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034529     DOI: 10.1007/s13277-014-2316-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

Review 1.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

Review 2.  MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship.

Authors:  Amy E Pasquinelli
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

3.  Menin is required for optimal processing of the microRNA let-7a.

Authors:  Buddha Gurung; Abdul Bari Muhammad; Xianxin Hua
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

Review 4.  Translating metastasis-related biomarkers to the clinic--progress and pitfalls.

Authors:  François-Clément Bidard; Jean-Yves Pierga; Jean-Charles Soria; Jean Paul Thiery
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

5.  Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

Authors:  Yekaterina Y Zaytseva; Piotr G Rychahou; Pat Gulhati; Victoria A Elliott; William C Mustain; Kathleen O'Connor; Andrew J Morris; Manjula Sunkara; Heidi L Weiss; Eun Y Lee; B Mark Evers
Journal:  Cancer Res       Date:  2012-01-19       Impact factor: 12.701

6.  Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis.

Authors:  Zhi Li Liu; Gao Wang; Ai Fen Peng; Qing Feng Luo; Yang Zhou; Shan Hu Huang
Journal:  Oncol Lett       Date:  2012-08-14       Impact factor: 2.967

7.  MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.

Authors:  Maria Inês Alvelos; João Vinagre; Elsa Fonseca; Eva Barbosa; José Teixeira-Gomes; Manuel Sobrinho-Simões; Paula Soares
Journal:  Eur J Endocrinol       Date:  2012-12-31       Impact factor: 6.664

8.  MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.

Authors:  Wei-Wei Shen; Zhi Zeng; Wen-Xia Zhu; Guo-Hui Fu
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

9.  Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription.

Authors:  Bin Xu; Shan-Hua Li; Rong Zheng; Shu-Bin Gao; Li-Hong Ding; Zhen-Yu Yin; Xiao Lin; Zi-Jie Feng; Sheng Zhang; Xiao-Min Wang; Guang-Hui Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

10.  C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway.

Authors:  Gang Han; Yan Wang; Wenzhi Bi
Journal:  Oncol Res       Date:  2012       Impact factor: 5.574

View more
  5 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6.

Authors:  Liang Wang; Jianli Shao; Xia Zhang; Meng Xu; Jianfu Zhao
Journal:  Tumour Biol       Date:  2015-01-11

3.  miR-142-3p inhibits cancer cell proliferation by targeting CDC25C.

Authors:  Xu-Chen Cao; Yue Yu; Li-Kun Hou; Xiao-Hu Sun; Jie Ge; Bin Zhang; Xin Wang
Journal:  Cell Prolif       Date:  2016-01-25       Impact factor: 6.831

4.  Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-κB signaling.

Authors:  Jianhong Qiang; Tingting Lv; Zhenbiao Wu; Xichao Yang
Journal:  Biosci Rep       Date:  2019-07-08       Impact factor: 3.840

5.  Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.

Authors:  Jingxuan Wang; Xiao Zhang; Jinming Shi; Paul Cao; Meimei Wan; Qiang Zhang; Yunxuan Wang; Steven J Kridel; Wennuan Liu; Jianfeng Xu; Qingyuan Zhang; Guangchao Sui
Journal:  Oncotarget       Date:  2016-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.